Author:
Ferenci Peter,Asselah Tarik,Foster Graham R.,Zeuzem Stefan,Sarrazin Christoph,Moreno Christophe,Ouzan Denis,Maevskaya Marina,Calinas Filipe,Morano Luis E.,Crespo Javier,Dufour Jean-François,Bourlière Marc,Agarwal Kosh,Forton Daniel,Schuchmann Marcus,Zehnter Elmar,Nishiguchi Shuhei,Omata Masao,Kukolj George,Datsenko Yakov,Garcia Miguel,Scherer Joseph,Quinson Anne-Marie,Stern Jerry O.
Reference38 articles.
1. Boceprevir for previously treated chronic HCV genotype 1 infection;Bacon;N Engl J Med,2011
2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011
3. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011
4. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011
5. US Food and Drug Administration (FDA). Incivek (telaprevir) in combination with drugs peginterferon alfa and ribavirin (Incivek combination treatment): drug safety communication – serious skin reactions. ; 2012 [accessed 06.14].
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献